Apyx Medical (APYX) Shares Outstanding (2010 - 2026)

Apyx Medical (APYX) has reported Shares Outstanding (Entity) for 17 consecutive years, with $42.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 11.44% year-over-year to $42.1 million; the trailing twelve-month figure through Jun 2026 stood at $42.1 million (up 11.44% YoY), and the FY2025 full-year result was $41.8 million, up 10.56% from the prior year.
• Shares Outstanding (Entity) climbed to $42.1 million in Q2 2026 per APYX's latest filing, from $41.9 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $42.1 million in Q2 2026 and bottomed at $34.5 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $36.5 million across 5 years, with a median of $34.6 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Entity) gained 0.0% in 2024, then advanced 11.44% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $34.6 million in 2022, then advanced by 0.13% to $34.6 million in 2023, then grew by 9.09% to $37.8 million in 2024, then increased by 10.56% to $41.8 million in 2025, then increased by 0.79% to $42.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $42.1 million, $41.9 million, and $41.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.